< Back

'antineoplastic combined chemotherapy protocols'
Run an advanced search on this term

Search within:  

Sort results by:      



1-20 of 64   Next >
 
1.  
Optimal chemotherapy for recurrent ovarian cancer. 2001 Sep 21 (revised 2011 Nov 21). NGC:009858
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Lung cancer. The diagnosis and treatment of lung cancer. 2005 Feb (revised 2011 Apr). NGC:008662
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia. 2015 Jun. NGC:010735
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
6.  
Rituximab in lymphoma and chronic lymphocytic leukemia: a clinical practice guideline, version 3. 2005 Feb 17 (revised 2015 Mar 31). NGC:010715
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Systemic therapy for well and moderately differentiated unresectable pancreatic neuroendocrine tumours. 2012 Nov (revised 2015 Feb). NGC:010737
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Neoadjuvant or adjuvant therapy for resectable gastric cancer. 2000 Dec 6 (revised 2011 Apr 5). NGC:009857
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Castration-resistant prostate cancer: AUA guideline. 2013 Apr (revised 2015 Apr). NGC:010730
American Urological Association Education and Research, Inc. - Medical Specialty Society. View all guidelines by the developer(s)
10.  
Colorectal cancer. The diagnosis and management of colorectal cancer. 2005 Aug (revised 2014 Dec). NGC:010624
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA 142). 2008 May (revised 2014 Nov). NGC:010617
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy. 2013 Aug. NGC:010011
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
14.  
ACR Appropriateness Criteria® resectable stomach cancer. 2014. NGC:010683
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
ACR Appropriateness Criteria® locally advanced breast cancer. 1996 (revised 2011). NGC:008469
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
16.  
Practice parameters for the management of rectal cancer (revised). 1993 (revised 2013 May). NGC:009896
American Society of Colon and Rectal Surgeons - Medical Specialty Society. View all guidelines by the developer(s)
17.  
ACR Appropriateness Criteria® ductal carcinoma in situ. 1996 (revised 2014). NGC:010674
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
18.  
19.  
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia. 2015 Jun. NGC:010734
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
20.  
Bladder cancer: diagnosis and management. 2015 Feb 25. NGC:010690
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 64   Next >